Kathleen Adlard Selected Research

Kathleen Adlard Research Topics

3	Leukemia 06/2015 - 07/2013
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2015 - 10/2014
1	Flushing 01/2023
1	Neoplasms (Cancer) 01/2023
1	Sepsis (Septicemia) 01/2023
1	Pressure Ulcer (Bedsore) 09/2015
1	Residual Neoplasm 06/2015
1	Graft vs Host Disease (Graft-Versus-Host Disease) 06/2015
1	Pathologic Complete Response 06/2015
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2013
1	Infections 07/2013
1	Pain (Aches) 01/2004

2	Cytarabine (Cytosar-U)FDA LinkGeneric 10/2014 - 07/2013
1	Heparin (Liquaemin)FDA LinkGeneric 01/2023
1	S-(1,2,2-trichlorovinyl)-L-cysteineIBA 01/2023
1	Sorafenib (BAY 43-9006)FDA Link 06/2015
1	Etoposide (VP 16)FDA LinkGeneric 10/2014
1	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 10/2014
1	Bortezomib (Velcade)FDA Link 10/2014
1	Clofarabine (Clolar)FDA Link 07/2013

2	Drug Therapy (Chemotherapy) 10/2014 - 07/2013
1	Central Venous Catheters 01/2023
1	Extracorporeal Membrane Oxygenation 09/2015
1	Aftercare (After-Treatment) 10/2014
1	Pain Management 01/2004